# Surface Oncology Inc. (SURF)

Source: https://www.quantisnow.com/company/SURF
Generated: 2026-11-18T05:18:19.782Z

- Ticker: SURF
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2018
- Website: surfaceoncology.com

## About

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 (IgG4) monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; SRF813 targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8 to deplete immuno-suppressive cells. It also develops an earlier stage program targeting regulatory T cells. The company has a strategic collaboration agreement with Novartis Institutes for Biomedical Research, Inc. for the development of cancer therapies; and a license agreement with GlaxoSmithKline to develop, manufacture, and commercialize antibodies that targets SRF813, as well as a clinical trial collaboration with Roche Holding AG to evaluate SRF388. Surface Oncology, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

## Latest SURF news and filings

- 2023-09-15 23:27 UTC [SEC Form 15-12G filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-surface-oncology-inc-4974294)
- 2023-09-13 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-surface-oncology-inc-4967681)
- 2023-09-13 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-surface-oncology-inc-4967661)
- 2023-09-08 20:10 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surface-oncology-inc-4961854)
- 2023-09-08 20:09 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surface-oncology-inc-4961844)
- 2023-09-08 20:08 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surface-oncology-inc-4961838)
- 2023-09-08 20:07 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surface-oncology-inc-4961833)
- 2023-09-08 20:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surface-oncology-inc-4961826)
- 2023-09-08 20:05 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surface-oncology-inc-4961820)
- 2023-09-08 20:04 UTC [SEC Form POS AM filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-surface-oncology-inc-4961794)
- 2023-09-08 20:03 UTC [SEC Form POS AM filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-surface-oncology-inc-4961768)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Adams Chandra returned 23,884 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-adams-chandra-returned-23884-shares-to-the-4961727)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Sigal Charles Elliott returned 45,453 shares to the company](https://www.quantisnow.com/insight/sec-form-4-sigal-charles-elliott-returned-45453-shares-to-4961725)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Palombella Vito J. returned 87,212 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-palombella-vito-j-returned-87212-shares-to-4961722)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Goater Jeff returned 129,222 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-goater-jeff-returned-129222-shares-to-the-4961715)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Fees Jessica returned 101,915 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-fees-jessica-returned-101915-shares-to-the-4961714)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Rath Henry C. returned 44,971 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-rath-henry-c-returned-44971-shares-to-4961711)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Oneill Alison returned 56,686 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-oneill-alison-returned-56686-shares-to-the-4961705)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Grayzel David S. returned 2,945,453 shares to the company](https://www.quantisnow.com/insight/sec-form-4-grayzel-david-s-returned-2945453-shares-to-4961704)
- 2023-09-08 20:00 UTC [SEC Form 4] [SEC Form 4: Ross Robert W. returned 83,193 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-ross-robert-w-returned-83193-shares-to-4961703)
- 2023-09-08 13:26 UTC [SEC Form 25-NSE filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-surface-oncology-inc-4961005)
- 2023-09-08 13:21 UTC [SEC Form 8-K] [Surface Oncology Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/surface-oncology-inc-filed-sec-form-8-k-completion-of-acquisition-4961001)
- 2023-08-31 21:18 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-surface-oncology-inc-4948402)
- 2023-08-31 20:01 UTC [Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote "FOR" the Proposed Merger with Coherus BioSciences](https://www.quantisnow.com/insight/surface-oncology-announces-iss-and-glass-lewis-both-recommend-stockholders-4947868)
- 2023-08-30 20:34 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-surface-oncology-inc-4945778)
- 2023-08-30 20:32 UTC [SEC Form 425] [SEC Form 425 filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-surface-oncology-inc-4945766)
- 2023-08-30 20:31 UTC [SEC Form 8-K] [Surface Oncology Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/surface-oncology-inc-filed-sec-form-8-k-other-events-4945741)
- 2023-08-12 00:00 UTC [SEC Form 4] [SEC Form 4: Fees Jessica sold $8,868 worth of shares (9,434 units at $0.94), decreasing direct ownership by 8% to 101,915 units](https://www.quantisnow.com/insight/sec-form-4-fees-jessica-sold-8868-worth-of-shares-4886956)
- 2023-08-12 00:00 UTC [SEC Form 4] [SEC Form 4: Adams Chandra sold $3,667 worth of shares (3,901 units at $0.94), decreasing direct ownership by 11% to 30,899 units](https://www.quantisnow.com/insight/sec-form-4-adams-chandra-sold-3667-worth-of-shares-4886955)
- 2023-08-12 00:00 UTC [SEC Form 4] [SEC Form 4: Ross Robert W. sold $15,710 worth of shares (16,713 units at $0.94), decreasing direct ownership by 17% to 83,193 units](https://www.quantisnow.com/insight/sec-form-4-ross-robert-w-sold-15710-worth-of-4886954)
- 2023-08-12 00:00 UTC [SEC Form 4] [SEC Form 4: Oneill Alison sold $6,619 worth of shares (7,042 units at $0.94), decreasing direct ownership by 11% to 56,686 units](https://www.quantisnow.com/insight/sec-form-4-oneill-alison-sold-6619-worth-of-shares-4886953)
- 2023-08-02 11:15 UTC [Market Chatter] [Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate](https://www.quantisnow.com/insight/surface-oncology-q2-eps-046-misses-034-estimate-4830969)
- 2023-08-02 11:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-surface-oncology-inc-4830918)
- 2023-08-02 11:00 UTC [SEC Form 8-K] [Surface Oncology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/surface-oncology-inc-filed-sec-form-8-k-results-of-operations-4830834)
- 2023-08-02 11:00 UTC [Earnings] [Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023](https://www.quantisnow.com/insight/surface-oncology-reports-financial-results-and-corporate-highlights-for-second-4830714)
- 2023-07-28 01:43 UTC [Market Insight] [Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares](https://www.quantisnow.com/insight/downgrade-aside-cathie-wood-buys-12m-worth-of-sofi-shares-4808921)
- 2023-07-26 20:56 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-surface-oncology-inc-4800549)
- 2023-07-20 12:00 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-surface-oncology-inc-4774630)
- 2023-07-12 21:08 UTC [SEC Form 425] [SEC Form 425 filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-surface-oncology-inc-4748022)
- 2023-07-12 21:05 UTC [SEC Form 425] [SEC Form 425 filed by Surface Oncology Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-surface-oncology-inc-4748008)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SURF
- Earnings history: https://www.quantisnow.com/earnings/SURF
- Dividend history: https://www.quantisnow.com/dividends/SURF
- Insider transactions: https://www.quantisnow.com/insiders/SURF
- Options chain: https://www.quantisnow.com/options/SURF
- SEC 8-K filings only: https://www.quantisnow.com/company/SURF/8-k
- RSS and alerts for SURF: https://www.quantisnow.com/docs/rss-feeds.md
